The University of Southampton
University of Southampton Institutional Repository

Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey

Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey
Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey
Sexual dysfunction is a common but often unrecognized side effect of many antidepressants. Building upon the results of a previous investigation, this study aimed to assess the prevalence and impact of antidepressant-associated sexual dysfunction (AASD) in three European countries. A cross-sectional survey of 704 adults in Germany, Spain, and The Netherlands was used in the study. All participants had recently started taking a selective serotonin reuptake inhibitor or serotonin— noradrenaline reuptake inhibitor. Information about other medications and conditions known to impair sexual functioning was gathered, and changes in sexual functioning and the impact of such changes were assessed. The SF-12 and Arizona Sexual Experience Scale (ASEX) were administered to measure health status and sexual functioning. AASD was defined using ASEX scores and information regarding changes in sexual functioning. ASEX scores generally exceeded the threshold defining sexual dysfunction: 67.2% in the German, 79.4% in the Spanish, and 73.3% in the Dutch samples. The prevalence of AASD was conservatively estimated to be between 37.1% (German sample) and 61.5% (Spanish sample). Overall, 46.4% of male and 52.1% of female participants were classified with AASD. Patients classified with AASD reported significantly worse quality of life (QoL), self-esteem, mood, and relationships with partners, compared with non-AASD patients. There were significant differences between patients with and without AASD in SF-12 Mental Component scores, with AASD patients displaying poorer mental well-being. Sexual dysfunction is a frequent occurrence during antidepressant treatment, and is associated with reduced QoL and self-esteem, and negative effects on mood and relationships.
antidepressants, quality of life (QoL), selective serotonin reuptake inhibitor (SSRI), serotonin-noradrenaline reuptake inhibitor (SNRI), sexual dysfunction
0269-8811
489-496
Williams, V.S.L.
11900cd7-cc8f-4045-aae9-3284aff603f2
Edin, H.M.
b08992a8-261f-40c3-80a7-5e21ed90ba8c
Hogue, S.L.
8c3eac75-39e3-4a8f-8bc0-6b5ea6294cb6
Fehnel, S.E.
2f07df0a-66c0-47e9-bd2c-a37f91335e2f
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Williams, V.S.L.
11900cd7-cc8f-4045-aae9-3284aff603f2
Edin, H.M.
b08992a8-261f-40c3-80a7-5e21ed90ba8c
Hogue, S.L.
8c3eac75-39e3-4a8f-8bc0-6b5ea6294cb6
Fehnel, S.E.
2f07df0a-66c0-47e9-bd2c-a37f91335e2f
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e

Williams, V.S.L., Edin, H.M., Hogue, S.L., Fehnel, S.E. and Baldwin, D.S. (2010) Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. Journal of Psychopharmacology, 24 (4), 489-496. (doi:10.1177/0269881109102779).

Record type: Article

Abstract

Sexual dysfunction is a common but often unrecognized side effect of many antidepressants. Building upon the results of a previous investigation, this study aimed to assess the prevalence and impact of antidepressant-associated sexual dysfunction (AASD) in three European countries. A cross-sectional survey of 704 adults in Germany, Spain, and The Netherlands was used in the study. All participants had recently started taking a selective serotonin reuptake inhibitor or serotonin— noradrenaline reuptake inhibitor. Information about other medications and conditions known to impair sexual functioning was gathered, and changes in sexual functioning and the impact of such changes were assessed. The SF-12 and Arizona Sexual Experience Scale (ASEX) were administered to measure health status and sexual functioning. AASD was defined using ASEX scores and information regarding changes in sexual functioning. ASEX scores generally exceeded the threshold defining sexual dysfunction: 67.2% in the German, 79.4% in the Spanish, and 73.3% in the Dutch samples. The prevalence of AASD was conservatively estimated to be between 37.1% (German sample) and 61.5% (Spanish sample). Overall, 46.4% of male and 52.1% of female participants were classified with AASD. Patients classified with AASD reported significantly worse quality of life (QoL), self-esteem, mood, and relationships with partners, compared with non-AASD patients. There were significant differences between patients with and without AASD in SF-12 Mental Component scores, with AASD patients displaying poorer mental well-being. Sexual dysfunction is a frequent occurrence during antidepressant treatment, and is associated with reduced QoL and self-esteem, and negative effects on mood and relationships.

This record has no associated files available for download.

More information

Published date: 1 April 2010
Keywords: antidepressants, quality of life (QoL), selective serotonin reuptake inhibitor (SSRI), serotonin-noradrenaline reuptake inhibitor (SNRI), sexual dysfunction

Identifiers

Local EPrints ID: 148089
URI: http://eprints.soton.ac.uk/id/eprint/148089
ISSN: 0269-8811
PURE UUID: d39864b0-16cf-40fc-9308-36128f0575ad
ORCID for D.S. Baldwin: ORCID iD orcid.org/0000-0003-3343-0907

Catalogue record

Date deposited: 27 Apr 2010 10:38
Last modified: 14 Mar 2024 02:38

Export record

Altmetrics

Contributors

Author: V.S.L. Williams
Author: H.M. Edin
Author: S.L. Hogue
Author: S.E. Fehnel
Author: D.S. Baldwin ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×